406 related articles for article (PubMed ID: 7329968)
1. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
Rodrigues A; Cabrita A; Maia P; Guimarães S
Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
[TBL] [Abstract][Full Text] [Related]
4. Modification of peritoneal ultrafiltration capacity in children undergoing peritoneal dialysis.
Drachman R; Niaudet P; Gagnadoux MF; Broyer M
Int J Pediatr Nephrol; 1985; 6(1):35-40. PubMed ID: 3997371
[TBL] [Abstract][Full Text] [Related]
5. Changes in peritoneal membrane after continuous ambulatory peritoneal dialysis--a histopathological study.
Bertoli SV; Barone MT; Vago L; Bonetto S; De Vecchi A; Scalamogna A; Barbiano di Belgiojoso G
Adv Perit Dial; 1999; 15():28-31. PubMed ID: 10682067
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
7. Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model.
Rippe B; Venturoli D
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1035-43. PubMed ID: 17090782
[TBL] [Abstract][Full Text] [Related]
8. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization.
Santamaría B; Ucero AC; Reyero A; Selgas R; Ruiz-Ortega M; Catalán M; Egido J; Ortiz A
Nephrol Dial Transplant; 2008 Oct; 23(10):3307-15. PubMed ID: 18524790
[TBL] [Abstract][Full Text] [Related]
9. [Peritoneum as a dialysis membrane. II. Pathology].
Grzybowski A; Breborowicz A
Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636
[TBL] [Abstract][Full Text] [Related]
10. Is the peritoneal membrane durable indefinitely?
Hallett MD; Charlton B; Farrell PC
Adv Perit Dial; 1990; 6():197-201. PubMed ID: 1982808
[TBL] [Abstract][Full Text] [Related]
11. Morpho-functional study of peritoneum in peritoneal dialysis patients.
Bertoli SV; Buzzi L; Ciurlino D; Maccario M; Martino S
J Nephrol; 2003; 16(3):373-8. PubMed ID: 12832736
[TBL] [Abstract][Full Text] [Related]
12. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
[TBL] [Abstract][Full Text] [Related]
14. [Peritoneum as dialysis membrane--a morphologic study].
Korten G
Z Urol Nephrol; 1984 Dec; 77(12):721-7. PubMed ID: 6528754
[TBL] [Abstract][Full Text] [Related]
15. What is new in peritoneal dialysis in the years 2003-2004.
Grzegorzewska AE
Rocz Akad Med Bialymst; 2004; 49():170-3. PubMed ID: 15631336
[TBL] [Abstract][Full Text] [Related]
16. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
[TBL] [Abstract][Full Text] [Related]
17. Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis.
Shioshita K; Miyazaki M; Ozono Y; Abe K; Taura K; Harada T; Koji T; Taguchi T; Kohno S
Kidney Int; 2000 Feb; 57(2):619-31. PubMed ID: 10652040
[TBL] [Abstract][Full Text] [Related]
18. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients.
Dobbie JW; Lloyd JK; Gall CA
Adv Perit Dial; 1990; 6():3-12. PubMed ID: 1982832
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis E
Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
[TBL] [Abstract][Full Text] [Related]
20. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
